Department of Urology Research Award

Best Student Award for Overall Academic Excellence, Intellectual Accomplishments, and Outstanding Performance.

MBA in International Hospital and Healthcare Management. Performance Bonus for Exceptional Performance

Outstanding Resident/Fellow Teacher Award (2006 and 2007) Department of Urology, McGill University, Montreal, Canada

Merit for Outstanding Academic Performance The Saudi Arabian Cultural Mission (Consistent awardee)

Present Member, Middle East and North Africa Prostate Cancer Management Board

Present Chairman, Saudi Arabian Prostate Cancer Management Board

Member, King Faisal Specialist Hospital International (KFSHI) Board

Member, Astellas Advisory Board

Member, Janssen Advisory Board

Member, SAJA Advisory Board

Seminoma Presenting as a Polypoid Bladder Mass: Report of a Case. Turkish Journal of Pathology, 2013.

Robotic extramural excision of bladder wall leiomyoma. Urology Annals, 2014.

Renal Cell Carcinoma with Inferior Vena Caval Extension: Impact of Tumor Extent on Surgical Outcome. British Journal of Urology International, January 2009.

Robotic Partial Cystectomy for Lymphangioma of the Urinary Bladder in an Adult Woman. Canadian Urological Association Journal, February 2012; 6(1).

Saudi Oncology Society Clinical Management Guidelines for Prostate Cancer. Urology Annals, Supplement 3, March 2011.

PhD in Oncology, Fundação Pio XII, Barretos Cancer Hospital, Brazil

Master's in Oncology, Fundação Pio XII, Barretos, Brazil

Clinical Fellowship in Medical Oncology, Hospital São Lucas - Pontificia Universidade Catolica do Rio Grande do Sul, Brazil

Medical Residency in Internal Medicine, Universidade Federal do Rio Grande do Sul, Hospital de Clinicas de Porto Alegre, Brazil

MD in Medicine, Universidade Federal de Santa Maria, Brazil

AMRIGS Medical Qualification, Medical Association Rio Grande do Sul, Porto Alegre, RS, Brazil

Brazilian Society of Medical Oncology (SBOC)

American Society Clinical Oncology (ASCO)

European Society Medical Oncology (ESMO)

International Association for the Study of Lung Cancer (IASLC)

HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer. Dovepress, 2024.

Cardiology and Oncology - a meeting of giants. Revista da Associação Médica Brasileira, 2024.

Fifteen years of precision medicine in the lung cancer management: Perspectives and Challenges. Medical Research Archives, 2024.

Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC. Translational Oncology, 2023.

EGFR Mutation Detection in Brazilian Patients With Non-Small-Cell Lung Cancer: Lessons From Real-World Data Scenario of Molecular Testing. Journal of Gastrointestinal Oncology, 2023.

Fellow in Hematology/Oncology, Wayne State University School of Medicine, Detroit, Michigan, USA

Resident in Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA

Resident in Internal Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

MBBS, King Saud University School of Medicine, Riyadh, Saudi Arabia

Best Resident Case Presentation Award, Riyadh Military Hospital

The Upjohn Research Award for Outstanding Achievement in Cancer Research Detroit, Michigan

Cited in the 18th edition of the Marquis Who’s Who in the world

Member, American College of Physicians

Member, American Society of Clinical Oncology

Member, The European Society for Medical Oncology

Founding Member, Saudi Cancer Foundation (Eastern Province)

Member, El Iman Cancer Society (Jeddah)

Member, Saudi Cancer Society

Member, Saudi Oncology Society

Member, Saudi Society for GI Oncology

Prognostic significance of peritoneal metastasis from colorectal cancer treated with first-line triplet chemotherapy. World J Clin Cases, March 2022; 10(8): 2429–2438.

Outcomes and Prognostic Factors of Metastatic Gastric Cancer: A Single-Center Experience. Cureus, August 2022; 14(8): e28426.

Nationwide Prevalence of Hepatocellular Carcinoma in Saudi Arabia: A Population-Based Analysis for 2021. Journal of Hepatocellular Carcinoma, December 30, 2025; 12:3063-3076.

Docetaxel versus androgen receptor pathway inhibitors as first-line therapy for metastatic castration-resistant prostate cancer after doublet therapy: a multicenter retrospective study from Saudi Arabia. BMC Urology, December 22, 2025; 25(1):306.

Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Infusional Gemcitabine: Immune Cell Infiltration Analysis and Updated Survival. Cancers (Basel), December 2025; 17(24):3963.